Cómo Usar el Indicador de Tempus
Tempus AI is a precision medicine company based in Chicago, using artificial intelligence to help physicians and researchers deliver more targeted care....
Key fact: Tempus AI (TEM) reported Q1 2025 revenue of $255.7 million, up 75% year-over-year, with gross profit nearly doubling. Dato clave: The company's FDA 510(k) clearance for ECG-Low EF software represents the second AI product cleared in cardiology, strengthening its position in AI-powered diagnostics. Key fact: Options volume for Tempus AI has surged, with 48 unusual trades detected in a single day, showing a split sentiment of 43% bullish versus 45% bearish. Tempus AI is a precision medicine company based in Chicago, using artificial intelligence to help physicians and researchers deliver more targeted care. Its platform processes massive amounts of genomic, clinical, and outcomes data to create tools for faster diagnosis and more personalized treatment plans. The company was founded by Eric Lefkofsky, known for building tech-driven businesses, and is backed by a leadership team with deep experience in healthcare technology, research, and data science. Tempus AI has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful.